Japanese Encephalitis News and Research

RSS
Japanese encephalitis (previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito-borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae. Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may cause severe symptoms. One of the most important vectors of this disease is the mosquito ''Culex tritaeniorhynchus''. This disease is most prevalent in Southeast Asia and the Far East.
WRAIR researchers publish results from Plasmodium vivax malaria vaccine study

WRAIR researchers publish results from Plasmodium vivax malaria vaccine study

Researchers discover new JE virus transmission route

Researchers discover new JE virus transmission route

Vaccinations could have significant economic value

Vaccinations could have significant economic value

SLU researcher discovered world's first dengue vaccine

SLU researcher discovered world's first dengue vaccine

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

Columbia University professor recommends vaccination for people travelling abroad

Columbia University professor recommends vaccination for people travelling abroad

Canada funds 22 inventive ideas for improving health in low-resource countries

Canada funds 22 inventive ideas for improving health in low-resource countries

New research may help scientists develop treatments or vaccines for Dengue fever

New research may help scientists develop treatments or vaccines for Dengue fever

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

Rising temperature induces key changes in dengue virus

Rising temperature induces key changes in dengue virus

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

New research focuses on rapid identification of disease outbreaks

New research focuses on rapid identification of disease outbreaks

Sanofi Pasteur’s IMOJEV vaccine against Japanese encephalitis is now available in Australia

Sanofi Pasteur’s IMOJEV vaccine against Japanese encephalitis is now available in Australia

BMJ examines emergence of China as 'major new player' in global vaccine production

BMJ examines emergence of China as 'major new player' in global vaccine production

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

Sinovac first quarter sales increase 30.3% to $6.0M

Sinovac first quarter sales increase 30.3% to $6.0M

Computer model can predict malaria epidemics in India

Computer model can predict malaria epidemics in India

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

Experimental sublingual vaccine shows promise against influenza infection

Experimental sublingual vaccine shows promise against influenza infection